22-46308713-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016426.7(GTSE1):c.532G>A(p.Val178Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,580 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V178L) has been classified as Benign.
Frequency
Consequence
NM_016426.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GTSE1 | NM_016426.7 | c.532G>A | p.Val178Met | missense_variant | 4/12 | ENST00000454366.2 | |
GTSE1 | XM_047441391.1 | c.532G>A | p.Val178Met | missense_variant | 3/11 | ||
GTSE1 | XM_047441392.1 | c.532G>A | p.Val178Met | missense_variant | 4/10 | ||
GTSE1 | XR_007067974.1 | n.615G>A | non_coding_transcript_exon_variant | 4/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GTSE1 | ENST00000454366.2 | c.532G>A | p.Val178Met | missense_variant | 4/12 | 1 | NM_016426.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152268Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248786Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135066
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461312Hom.: 0 Cov.: 33 AF XY: 0.0000248 AC XY: 18AN XY: 726924
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152268Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74400
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 14, 2024 | The c.532G>A (p.V178M) alteration is located in exon 4 (coding exon 3) of the GTSE1 gene. This alteration results from a G to A substitution at nucleotide position 532, causing the valine (V) at amino acid position 178 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at